BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29124949)

  • 1. Reassessment of inclusion body-based production as a versatile opportunity for difficult-to-express recombinant proteins.
    Hoffmann D; Ebrahimi M; Gerlach D; Salzig D; Czermak P
    Crit Rev Biotechnol; 2018 Aug; 38(5):729-744. PubMed ID: 29124949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstream processing of Cry4AaCter-induced inclusion bodies containing insect-derived antimicrobial peptides produced in Escherichia coli.
    Hoffmann D; Eckhardt D; Gerlach D; Vilcinskas A; Czermak P
    Protein Expr Purif; 2019 Mar; 155():120-129. PubMed ID: 30529536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of an E. coli signal sequence as a versatile inclusion body tag.
    Jong WS; Vikström D; Houben D; van den Berg van Saparoea HB; de Gier JW; Luirink J
    Microb Cell Fact; 2017 Mar; 16(1):50. PubMed ID: 28320377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process.
    Sarker A; Rathore AS; Gupta RD
    Microb Cell Fact; 2019 Jan; 18(1):5. PubMed ID: 30642336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the disaggregase ClpB in processing of proteins aggregated as inclusion bodies.
    Zblewska K; Krajewska J; Zolkiewski M; Kędzierska-Mieszkowska S
    Arch Biochem Biophys; 2014 Aug; 555-556():23-7. PubMed ID: 24943258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study to develop a single method for retrieving wide class of recombinant proteins from classical inclusion bodies.
    Padhiar AA; Chanda W; Joseph TP; Guo X; Liu M; Sha L; Batool S; Gao Y; Zhang W; Huang M; Zhong M
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2363-2377. PubMed ID: 29387954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of inclusion body-forming peptides and proteins in soluble form by fusion to Escherichia coli thermostable proteins.
    Thapa A; Shahnawaz M; Karki P; Raj Dahal G; Sharoar MG; Yub Shin S; Sup Lee J; Cho B; Park IS
    Biotechniques; 2008 May; 44(6):787-96. PubMed ID: 18476832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli.
    Wei Q; Kim YS; Seo JH; Jang WS; Lee IH; Cha HJ
    Appl Environ Microbiol; 2005 Sep; 71(9):5038-43. PubMed ID: 16151084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of functional inclusion bodies in endotoxin-free Escherichia coli.
    Rueda F; Cano-Garrido O; Mamat U; Wilke K; Seras-Franzoso J; García-Fruitós E; Villaverde A
    Appl Microbiol Biotechnol; 2014 Nov; 98(22):9229-38. PubMed ID: 25129611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of active inclusion bodies induced by hydrophobic self-assembling peptide GFIL8.
    Wang X; Zhou B; Hu W; Zhao Q; Lin Z
    Microb Cell Fact; 2015 Jun; 14():88. PubMed ID: 26077447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.
    Krachmarova E; Ivanov I; Nacheva G
    Microb Cell Fact; 2020 Jul; 19(1):139. PubMed ID: 32652996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refolding solubilized inclusion body proteins.
    Burgess RR
    Methods Enzymol; 2009; 463():259-82. PubMed ID: 19892177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.
    Yamaguchi H; Miyazaki M
    Biomolecules; 2014 Feb; 4(1):235-51. PubMed ID: 24970214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli.
    Wurm DJ; Quehenberger J; Mildner J; Eggenreich B; Slouka C; Schwaighofer A; Wieland K; Lendl B; Rajamanickam V; Herwig C; Spadiut O
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):667-676. PubMed ID: 29159587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications.
    Roca-Pinilla R; Fortuna S; Natalello A; Sánchez-Chardi A; Ami D; Arís A; Garcia-Fruitós E
    Microb Cell Fact; 2020 Sep; 19(1):175. PubMed ID: 32887587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of recombinant antimicrobial peptides in bacteria.
    Zorko M; Jerala R
    Methods Mol Biol; 2010; 618():61-76. PubMed ID: 20094858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization and refolding of inclusion body proteins.
    Singh A; Upadhyay V; Panda AK
    Methods Mol Biol; 2015; 1258():283-91. PubMed ID: 25447870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of inclusion bodies for bio-based products: curse or blessing?
    Slouka C; Kopp J; Spadiut O; Herwig C
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1143-1153. PubMed ID: 30569219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant production of biologically active giant grouper (Epinephelus lanceolatus) growth hormone from inclusion bodies of Escherichia coli by fed-batch culture.
    Chung WJ; Huang CL; Gong HY; Ou TY; Hsu JL; Hu SY
    Protein Expr Purif; 2015 Jun; 110():79-88. PubMed ID: 25703054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategic optimization of conditions for the solubilization of GST-tagged amphipathic helix-containing ciliary proteins overexpressed as inclusion bodies in E. coli.
    Shendge AA; D'Souza JS
    Microb Cell Fact; 2022 Dec; 21(1):258. PubMed ID: 36510188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.